期刊
VACCINES
卷 9, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/vaccines9040316
关键词
SARS-CoV-2; spike; neutralizing activity; RBD-hACE2 inhibition; cellular immunity; aged mice
资金
- NIH/NIAID [AI093772]
SARS-CoV-2 vaccines are facing supply and production challenges, and the efficacy in elderly populations remains unknown. Full-length S vaccine is more immunogenic in inducing IgG antibodies, while S1 subunit can induce neutralizing and receptor-binding inhibiting antibodies at high dose. Adjuvant effects are significant for effective immune responses induction.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be expanding the pandemic disease across the globe. Although SARS-CoV-2 vaccines were rapidly developed and approved for emergency use of vaccination in humans, supply and production difficulties are slowing down the global vaccination program. The efficacy of many different versions of vaccine candidates and adjuvant effects remain unknown, particularly in the elderly. In this study, we compared the immunogenic properties of SARS-CoV-2 full-length spike (S) ectodomain in young adult and aged mice, S1 with receptor binding domain, and S2 with fusion domain. Full-length S was more immunogenic and effective in inducing IgG antibodies after low dose vaccination, compared to the S1 subunit. Old-aged mice induced SARS-CoV-2 spike-specific IgG antibodies with neutralizing activity after high dose S vaccination. With an increased vaccine dose, S1 was highly effective in inducing neutralizing and receptor-binding inhibiting antibodies, although both S1 and S2 subunit domain vaccines were similarly immunogenic. Adjuvant effects were significant for effective induction of IgG1 and IgG2a isotypes, neutralizing and receptor-binding inhibiting antibodies, and antibody-secreting B cell and interferon-gamma secreting T cell immune responses. Results of this study provide information in designing SARS-CoV-2 spike vaccine antigens and effective vaccination in the elderly.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据